Biotech

Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight
Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Evaxion Biotech Partners With Merck To Expand Vaccine Development

Biotech Recent News

This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.
US Intelligence Claims Chinese Pharma Giant Illegally Shared Secrets With Beijing
U.S. intelligence officials have informed senators that WuXi AppTec, a Chinese pharmaceutical company, allegedly transferred U.S. intellectual property to Beijing without authorization. This news comes amid concerns that certain Chinese biotech firms are providing technology or research and development for use by the Chinese military.
Nvidia, Boeing, Ardelyx, Crocs, Tesla: Why These 5 Stocks Are On Investors' Radars Today
These Biotech Stocks Could Double Your Money, According To Analysts
Elon Musk Questioned By Ethics Group Over Painful Deaths Of Monkeys Linked To Neuralink
Elon Musk is facing another round of allegations from an ethics group questioning him on the death of monkeys at biotech startup Neuralink.
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.
The Secret Behind Why Your Coffee and CBD Might Not Be Working
J&J Investors Will Soon Be Able To Exchange Shares For Kenvue Stocks
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
The Companies That Led 2017's Biotech Rally
10 Biotech Stocks Moving From ASH 2017
It's A Bad Day For Biotechs
Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead
A Sign Of Things To Come? Traders Are Betting On More Biotech Mergers
Small Biotechs Could Hurt From Scarcity Of Cancer Trial Participants
FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health
Following Extended Consolidation Period, Biotech ETF's Next Breakout Could Be Big
Exclusive: CBMG CEO Talks Stem-Cell Therapies, Cancer Treatments, Financials & The Chinese Market
Viridian's President On Cannabis-Related Opportunities: AgTech And BioTech Offer Value To Investors
Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff
Assessing The Legitimacy Of The Biotech ETF Bounce
4 Election-Proof Stocks: Biotech And Software Take The Lead
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved